Cell & Gene Therapy Research & Development Congress Asia
07
Mar
-
08
Mar
2022
When
Taipei 
Taiwan
Where

Although regenerative therapies are relatively new, more & more hospitals are incorporating cell and gene treatments to treat patients, driving up investment in this sector. World-wide 30 cell and gene therapies have been authorised for large scale production.

Similar Events

You May Like

Event

Global Engage

0/5
(0)

Producing high level conferences and summits for the Pharmaceutical, Medical and Agricultural Biotechnology sectors our experienced team of researchers provides you with the opportunity to share knowledge, network and most importantly find sources of

07 - 08 Mar 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Associate Director - Allogeneic CAR-T
Co-Founder & Chief Scientist
President and Chief Scientific Officer
Sr Application Scientist, Cell & Gene Therapy (APJ)
Strategic Technology Partnership Leader CGT, APAC
Sr. Director / Site Head of Quality

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Twist Bioscience

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA.

Pall Corporation

Across 80 Pall locations and 10,000 people worldwide, we are unified by a singular drive: to take on our customers’ biggest challenges. To solve the critical problems that stand in the way of advancing health, safety and the environment.

GenScript

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.

Organizer

Get emails from us

Thank you
Oops! Something went wrong